Difficulty: Medium
Average Score: 76%
Practice
Of the following, the MOST appropriate initial therapy for a 12-year-old female adolescent with mild arthritis and a faint malar rash is
Correct answer
C
Rationale
In the case of a 12-year-old female adolescent with mild arthritis and a faint malar rash, the most appropriate initial therapy is hydroxychloroquine (Option C). This choice is based on the consideration of the patient's age, symptoms, and the most conservative approach to treatment.
Hydroxychloroquine is a disease-modifying antirheumatic drug (DMARD) commonly used in the treatment of mild arthritis in children due to its favorable safety profile compared to other DMARDs. It is particularly effective in managing mild symptoms and can help control the autoimmune response that leads to arthritis and rash in this case.
Steroids (Option A) may be effective in suppressing inflammation but are generally not the first choice due to their potential long-term side effects, especially in children. Systemic methotrexate (Option B) and cyclophosphamide (Option D) are more potent medications typically reserved for more severe cases of arthritis and lupus, and their use in mild cases without trying milder options first would not be appropriate.
In an educational context, it is essential for healthcare providers to consider the patient's age, disease severity, potential side effects of medications, and the goal of achieving symptom control with the least harm. Understanding the hierarchy of treatment options and tailoring therapy to the individual patient's needs are crucial aspects of pediatric nursing practice.
Hydroxychloroquine is a disease-modifying antirheumatic drug (DMARD) commonly used in the treatment of mild arthritis in children due to its favorable safety profile compared to other DMARDs. It is particularly effective in managing mild symptoms and can help control the autoimmune response that leads to arthritis and rash in this case.
Steroids (Option A) may be effective in suppressing inflammation but are generally not the first choice due to their potential long-term side effects, especially in children. Systemic methotrexate (Option B) and cyclophosphamide (Option D) are more potent medications typically reserved for more severe cases of arthritis and lupus, and their use in mild cases without trying milder options first would not be appropriate.
In an educational context, it is essential for healthcare providers to consider the patient's age, disease severity, potential side effects of medications, and the goal of achieving symptom control with the least harm. Understanding the hierarchy of treatment options and tailoring therapy to the individual patient's needs are crucial aspects of pediatric nursing practice.